Cell migration plays a crucial role in a variety of (patho)physiological processes such as immune defense, wound healing, and formation of tumor metastases. Detailed models have been developed to describe cytoskeletal mechanisms of migration. However, evidence is accumulating that the activity of ion channels and transporters is also required for optimal cell locomotion.
C ell migration is an important physiological and pathophysiological process throughout life. From early in embryogenesis, cells are migrating through our bodies. Neural crest cells are migrating through the embryo to form the nervous system. Neuroblasts are moving within the central nervous system even after birth to reach their final place of work. Leukocytes are chasing invading bacteria or other pathogens, or they are crawling into sites of inflammation. Fibroblasts are migrating into a wound and thereby contributing to its closure. The same holds true for epithelial cells, which close smaller gaps in an epithelial layer by migrating along the basement membrane. Angiogenesis requires migration of endothelial cells, and atherosclerosis involves migration of smooth muscle cells. Finally, migrating tumor cells may be responsible for terminating life, since tumor cell migration is one of the crucial steps in the metastatic cascade.
The rates at which cells migrate vary considerably from cell type to cell type. Some epithelial cells or granular cells from the cerebellum move only a fraction of a micrometer per minute. The "professionals" such as neutrophil granulocytes are much faster: their rate of migration is 5-10 µm/min. Fish keratocytes are even faster than neutrophils. They can slide over their substratum at rates of up to 30 µm/min.
Despite these differences in function and speed, migrating cells share many similarities with respect to mechanisms of migration. A migrating cell is typically polarized within the plane of movement (Fig. 1) . One can easily distinguish front and rear end, in particular when cells are crawling over a two-dimensional surface. The front is formed by a flat (~300 nm thin), organelle-free, fan-like process, the so-called lamellipodium. The rear end is formed by the prominent cell body that extends into a uropod. Different cytoskeletal mechanisms take place at the front and at the rear of migrating cells to allow efficient locomotion. Protrusion of the lamellipodium and retraction of the cell body do not always occur in parallel. The retraction of the rear edge may lag behind the extension of the lamellipodium in slowly migrating cells such as fibroblasts. Consequently, a cell can grow in length for several minutes before the cell body eventually "catches up." The clear separation between front and rear parts of migrating cells offers a great experimental advantage. The functional properties of these cell poles can be studied individually. For example, it is possible to direct inhibitors of membrane proteins to just one cell pole at a time (Fig. 2) .
Cytoskeletal mechanisms of migration
Cytoskeletal mechanisms of migration have been studied in great detail. Here only a brief overview will be given of those mechanisms that potentially interact or act in concert with ion transporters and ion channels during migration (Ref. 6 and references cited therein provide a detailed review of this field). Actin filaments play a central role in cell migration. They form a dense meshwork in the lamellipodium. Actin filaments grow in the direction of locomotion at the leading edge of the lamellipodium and thereby drive the protrusion of this cell pole. Actin filaments interact with a great variety of other proteins that are important for their polymerization, dynamic turnover, and structural organization into a cross-linked network. The retraction of the rear end of a migrating cell is thought to be related to the contraction of the cortical actomyosin network underneath the cell membrane. This view is also supported by the finding that myosin II is concentrated at the rear end of some migrating cells. The functional polarization of cytoskeletal mechanisms is also maintained by a gradient of the intracellular Ca 2+ concentration ([Ca   2+ ] i ), with [Ca 2+ ] i being higher at the rear end than in the lamellipodium. The cytoskeleton can only translocate a cell when the forces generated by the cellular "migration machinery" are transmitted to the surrounding extracellular matrix. When there is too little friction and cells can form no contacts with their substratum, locomotion is impaired. Similarly, locomotion is also impaired when the substratum is too "sticky" and cells cannot release their contacts. Thus the interaction between extracellular matrix and cell adhesion receptors has to be a highly coordinated process. It depends on the concentration of extracellular matrix proteins and the expression level of integrins, the cellular adhesion receptors (8). Moreover, the matrix contacts are dynamic and asymmetric. Thus a migrating cell forms new contacts at its front, and contacts are released at the rear of a cell. Sometimes, integrins are left behind (shed), so one can visualize a cell's path retrospectively by staining the shed integrins with the appropriate antibodies.
Ion channels and transporters are involved in cell migration
The function of ion channels and transporters is closely related to the actin cytoskeleton. On one hand, ion channels and transporters can be regulated by the state of actin filaments. This is of particular importance during cell volume regulation when swollen or shrunken cells try to restore their normal volume by means of activating ion channels and transporters. Volume regulation is impaired when the normal actin filament turnover is disturbed by drugs such as cytochalasin, which prevents the growth of actin filaments. In addition, the organization of the actin filament network by accessory proteins also modulates the ability of a cell to regulate its volume. Melanoma cells, which lack an actin filament cross-linking protein (ABP280), are unable to activate a K + channel adequately during volume regulation (1) . Thus the state of the actin cytoskeleton is of critical importance for the appropriate activation of ion channels and transporters during volume regulation.
On the other hand, changes of cell volume themselves in turn influence the actin cytoskeleton. Such volume changes can be elicited among others by activating or inhibiting ion channels and transporters. Cell swelling is accompanied by a disintegration of actin filaments, and cell shrinkage is followed by an assembly of actin filaments. The interdependence of actin filaments and cell volume indicates that the "correct" cell volume and thereby the "correct" activity of ion channels and transporters must play an important role in cell migration, a process critically relying on a rapid turnover of actin filaments. By setting the correct cell volume, ion channels and transporters create the intracellular milieu that is required for the optimal operation of the cytoskeletal migration machinery.
This concept has now been tested in several cell types for a number of ion channels and transporters. Human melanoma cells, which lack the actin cross-linking protein ABP280, are unable to migrate. Interestingly, they are also unable to activate K + channels appropriately during volume regulation. Both defects are rescued by transfecting these cells with ABP280 (1). Conversely, migration of these rescued melanoma cells is impaired when Ca 2+ -sensitive K + channels (IK1) are blocked. This type of K + channel is required for migration of other cell types too (14). Thus IK1 channel activity appears to be a general requirement for cell migration. This conclusion is indirectly supported by the expression pattern of IK1 channels. They are predominantly found in cells with the ability to migrate. A different type of K + channel, the voltage-dependent Kv3.1, was related to migration of embryonic nerve cells (3). K + channels are, however, not the only ion channels found to be necessary for cell migration. Migration of granular cells from the cerebellum depends on the activity of N-type Ca 
Ion channels and transporters support migration in different ways
Depending on their type, ion channels or transporters modulate the cytoskeletal migration machinery in one of two ways: by modifying either the [Ca 2+ ] i or the volume of migrating cells. Although these mechanisms will be discussed separately, they are probably closely interrelated with each other.
[ ] i , which is higher in the rear part than in the front of migrating cells, is an important regulator for a number of cytoskeletal proteins. High [Ca 2+ ] i in the rear promotes the retraction of the rear part of a migrating cell. In contrast, low [Ca 2+ ] i in the front will favor the protrusion of the lamellipodium. This spatial component of Ca 2+ signaling on the intracellular migration machinery has superimposed on it a temporal component involving fluctuations in [Ca 2+ ] i in migrating cells. Thus the alternating predominance of mechanisms leading to the retraction of the rear part or to the protrusion of the lamellipodium is necessary for optimal cell locomotion. ] i also activate IK1 channels in migrating cells. Studies of volume regulation show that activation of these K + channels is followed by cell shrinkage. Such volume loss due to activation of IK1 channels also occurs in migrating cells. Oscillations of [Ca 2+ ] i trigger the intermittent loss of up to 20% of the cell volume (12). Since blockade of IK1 channels prevents volume fluctuations and inhibits migration, we postulated that K + channel-mediated volume fluctuations are part of or modulate the cellular migration machinery. In a similar way, a Cl -channel was suggested to modulate migration of glioma cells (15). The question that arises is how intermittent volume loss contributes to cell migration. A clue comes from experiments in which we applied the scorpion venom charybdotoxin, a blocker of IK1 channels, exclusively to the lamellipodium or to the cell body of migrating cells. Migration is only inhibited when the rear part of a crawling cell is exposed to the blocker (Ref. 13; Fig. 2A ). Consequently, IK1 channel-mediated volume changes almost exclusively affect the rear part of migrating cells (12). Thus IK1 channels facilitate the retraction of the rear part of migrating cells by inducing a local cell shrinkage at this cell pole.
If local cell shrinkage is associated with the retraction of the rear part of migrating cells, it appears logical that the protrusion of the lamellipodium would be accompanied by a local cell swelling. In such a scenario, transporters mediating solute uptake and, thereby, osmotically obliged water influx had to be present in the lamellipodium. NHE1 and AE2 are two of the candidate transporters. Both transporters are required for optimal cell migration (4, 10, 11). Indeed, they are both concentrated at the leading edge of the lamellipodium of migrating cells (2, 4). NHE1 colocalizes with proteins of cell adhesion complexes at this cell pole (2). Immunocytochemical localization of the exchangers matches very well with functional data. As depicted in Fig. 2B , inhibitors of NHE1 or AE2 impair migration only when they are directed to the lamellipodium. They have no effect on migration when directed to the rear part of a migrating cell ( Ref. 4; Fig. 2B ).
On the basis of these findings, we propose the following cycle of events to explain the contribution of ion channels and transporters to cell migration (Fig. 3) ] i and a shrunken cell volume could favor actin filament polymerization and the outgrowth of the lamellipodium. Cell volume is replenished by NHE1 and AE2 activity, ] i returns to basal levels, and the cycle starts all over again. In a simplified view, one can therefore describe migration as temporally and spatially separated phases of local cell swelling and cell shrinkage.
Perspectives
Studies on the role of ion channels and ion transporters in cell migration are at an early stage. The model outlined above still needs detailed experimental verification. In particular, the exact molecular mechanisms by which ion transport affects the cytoskeletal migration machinery are not yet known. Nonetheless, these studies show that ion channels and transporters may be of potential therapeutic use in disease states in which cell migration plays an important pathophysiological role. The experiments on ion channels and transporters reveal a novel, fascinating aspect of cell migration. The polarization of a migrating cell within the plane of movement is also reflected in the subcellular distribution of these transport proteins. Some channel and transporter proteins are concentrated at the leading edge of the lamellipodium of migrating cells (2, 4, 9). These findings show that membrane domains with distinct functional properties are present not only in differentiated epithelial or neuronal cells but in migrating cells as well. Future studies will therefore need to focus on the mechanisms underlying the polarized distribution of transport proteins in the plasma membrane of migrating cells. 
I
t has been nearly 100 years since Bayliss (2) described antidromic vasodilation following electric stimulation of centrally cut dorsal roots. Following this first description of efferent functions of afferent nerve fibers, our knowledge about their mechanisms has considerably increased. Various neuropeptides and the receptors responsible for their efferent functions have been identified. Pivotal peptides in the induction of neurogenic inflammation comprise calcitonin gene-related peptide (CGRP) and substance P (SP). However, a variety of neuropeptides, such as neurokinin A, neurokinin B, somatostatin, galanin, and, recently, endomorphins, have been found in primary afferent neurons.
Activation of thin nociceptive nerve endings in the skin generates action potentials that are conducted by their axons to the spinal cord, and after processing of this nociceptive information, finally a sensation of pain or itch may be generated in the central nervous system. However, the action potentials will also retrogradely invade the arborizations of the primary afferent neuron ("axon reflex") and release neuropeptides from their terminals (15) (Fig. 1) .
Neuronal basis of neurogenic inflammation
Chemical, thermal, and electric stimulation have been widely used to elicit neurogenic inflammation. As a result of previous studies, mechanoinsensitive, but heat-and chemosensitive, C nociceptors have been found responsible for the neurogenic vasodilation in pig skin (9). Direct evidence of neuropeptide release has been obtained using capsaicin, the pungent constituent of hot chili pepper, as well as by antidromic electric nerve stimulation (6, 7).
It was generally believed that receptive fields of nociceptors in human skin are too small to account for the widespread flare that is elicited, for example, after a histamine stimulation. Therefore, a cascade theory was proposed that was based on the activation of cutaneous mast cells in the axon reflex flare reaction. This concept, which suggests that SP released from nociceptive terminals should activate cutaneous mast cells that in turn should activate chemonociceptors via the release of histamine, is described in detail elsewhere (8).
Neuropeptide-mast cell interaction
Studies of neuropeptide-mast cell interaction have, to a large extent, been performed in peritoneal or dispersed connective tissue mast cells in rodents. Furthermore, many in 
